Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - OncoMed Pharmaceuticals Inc | d607389d10q.htm |
| EX-31.2 - EX-31.2 - OncoMed Pharmaceuticals Inc | d607389dex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - OncoMed Pharmaceuticals Inc | Financial_Report.xls |
| EX-10.9 - EX-10.9 - OncoMed Pharmaceuticals Inc | d607389dex109.htm |
| EX-31.1 - EX-31.1 - OncoMed Pharmaceuticals Inc | d607389dex311.htm |
| EX-10.8 - EX-10.8 - OncoMed Pharmaceuticals Inc | d607389dex108.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of OncoMed Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended September 30, 2013, as filed with the Securities and Exchange Commission (the “Report”), Paul J. Hastings, Chairman and Chief Executive Officer of the Company, and William D. Waddill, Senior Vice President and Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| • | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| • | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 13, 2013
| /s/ Paul J. Hastings |
| Paul J. Hastings |
| Chairman and Chief Executive Officer (principal executive officer) |
| /s/ William D. Waddill |
| William D. Waddill |
| Senior Vice President and Chief Financial Officer (principal financial and accounting officer) |